Abstract
A prospective clinical parametric study comprising women afflicted by breast cancer and otherwise healthy participants was undertaken. The mean plasmatic concentration of putative leucine amino peptidase and nucleoside diphosphate phosphotransferase enzymatic complex in breast cancer cases was significantly elevated [43.9±2.8 μg ml−1 (n=9)] when compared to those found in otherwise healthy women [8.07±0.14 μg ml−1 (n=8)]. Women without images compatible with any tumours (n=13) had a mean concentration of 10.77±1.49 μg ml−1. The mean value obtained in women with fibroadenomas was 10.15±0.81 μg ml−1 (n=6) and with cystic fibrosis mastopathy 8.75±0.28 μg ml−1 (n=7). The efficacy of a tandem quantitative biodiagnostic system as a parametric screening tool for the early detection of breast cancer is underlined, raising the possibility of increasing the cost effectiveness of current imaging non-parametric technologies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the million women study. Lancet 362: 419-427.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin. Chem. 49: 1-6.
Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 289: 3243-3253.
Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. N.Engl.J.Med. 338: 1089-1096.
Fletcher SW, Elmore JG (2003) Mammographic screening for breast cancer. N. Engl. J. Med. 348: 1672-1680.
Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J. Bioenerg. Biomembr. 32: 247-258.
Larkin M(2001) Breast self examination does more harm than good, says task force. Lancet 357: 2109.
Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279: 915-921.
Parkin M (2001) Global cancer statistics in the year 2000. Lancet Oncol. 2: 533-542.
Pulido-Cejudo G (1994) Monoclonal antibodies directed against NDP-Kinase. Canadian Patent 2,108,533, Ministry of Health Canada.
Pulido-Cejudo G (2001) A monoclonal antibody against estrogen stimulated leucine aminopeptidase. Canadian Patent 2,303,505, Ministry of Health Canada.
Pulido-Cejudo G (2003) Tandem immnuo-assay for cancer. US Patent 6,521,415 B1, Ministry of Health Canada.
Pulido-Cejudo G, Gagnon J, Leclerc JM, Jamison K, Gordon J, Campione-Piccardo J (1994) Measurement of nucleoside diphosphate kinase-Nm23 activity by anion-exchange high-performance liquid chromatography. J. Chromatogr. B, Biomed. Appl. 660: 37-47.
Pulido-Cejudo G, Jamison K, Alderdice S, Burke K, Pulido A (1999) Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards HIV infection. In: Skouteris GG, Nicolson GL, eds. Intermolecular Cross-Talk in Tumour Metastasis. Vol. 311, 1st edn. Amsterdam: IOS Press, pp. 123-136.
Roymans D, Willems R, Van Blockstaele DR, Slegers H (2002) Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with the multiple partners: possible consequences in tumour metastasis. Clin. Exp. Metastasis 19: 465-476.
Shekhar PVM, Werdel J, Basrur VS (1997) Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J. Natl. Cancer Inst. 89: 1774-1782.
Wassertheil-Smoller S (2004) Biostatistics and Epidemiology, 3rd edn. New York: Springer.
Wooster R, Bignell G, Lancaster JM, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pulido-Cejudo, G., Miranda, H., El Abdaimi, K. et al. A monoclonal antibody driven biodiagnostic system for the quantitative screening of breast cancer. Biotechnology Letters 26, 1335–1339 (2004). https://doi.org/10.1023/B:BILE.0000045629.57791.5a
Issue Date:
DOI: https://doi.org/10.1023/B:BILE.0000045629.57791.5a